Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Elanco Animal Health Incorporated Common Stock (NY:ELAN)

25.70 +0.09 (+0.35%)
Streaming Delayed Price Updated: 2:24 PM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Elanco Animal Health Incorporated Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
Ancora Nominates Four Highly Qualified, Independent Director Candidates and Urges Orderly CEO Succession at Elanco Animal Health
From Ancora Holdings Group, LLC
Via Business Wire
News headline image
Merck Animal Health to Acquire Elanco’s Aqua Business
From Merck & Co., Inc.
Via Business Wire
News headline image
Elanco to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Elanco to Participate in Evercore ISI 6th Annual HealthCONx Conference
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Elanco Animal Health Reports Third Quarter 2023 Results
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Athian and Elanco Animal Health Team Up to Transform Food Production through Methane Reduction
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Elanco Confirms Date and Conference Call for Third Quarter 2023 Financial Results Announcement
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Elanco Announces Corporate Governance Enhancements
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Elanco Launches Varenzin™-CA1 (molidustat oral suspension) – the First-of-its-Kind Oral Treatment for Anemia in Cats with Chronic Kidney Disease
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Elanco to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Elanco Animal Health Reports Second Quarter 2023 Results and Raises Full Year Guidance
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Elanco Releases 2022 Environmental, Social and Governance Report, Demonstrating Sustainability Progress in Internal Operations and Customer Collaborations
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Elanco Confirms Date and Conference Call for Second Quarter 2023 Financial Results Announcement
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Environmental Protection Agency (EPA) Completes Review of Seresto® Collar and Confirms Continued Registration; Data Affirms Safety Profile of the Product
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Bullish or Bearish? Vetting Animal Health Care Stocks
Americans are paying more and more attention to pet health, making pet care stocks look healthy again. Here are two names worth a check up. 
Via MarketBeat
Topics ETFs
News headline image
Elanco to Participate in Goldman Sachs 44th Annual Global Healthcare Conference
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Elanco to Participate in Stifel 2023 Jaws and Paws Conference
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Zoetis Declares New Dividend, Hinting At Undervaluation
Zoetis shareholders woke up to news of JAB's acquisition of Pumpkin, a per insurance platform where Zoetis owns a minority stake. 2023 outlooks suggest a rally 
Via MarketBeat
News headline image
Elanco Animal Health Reports First Quarter 2023 Results
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Elanco Announces Breakthrough Treatment for Deadly Canine Parvovirus
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Elanco Confirms Date and Conference Call for First Quarter 2023 Financial Results Announcement
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Elanco to Participate in the Barclays Global Healthcare Conference
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Elanco to Participate in the Cowen 43rd Annual Health Care Conference
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Elanco to Participate in the Bank of America 2023 Animal Health Summit
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Elanco Animal Health Reports Fourth Quarter and Full Year 2022 Results
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Elanco Adds Animal Health Veteran to Executive Committee
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Zoetis, Pet-Med Specialist, Double-Digit Earnings Growth Ahead
Animal health company Zoetis is up 7.99% in the past week, after topping fourth-quarter views. Analysts see double-digit EPS growth in 2023 and 2024. 
Via MarketBeat
News headline image
Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2022 Financial Results Announcement
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Elanco to Participate in the 41st Annual J.P. Morgan Healthcare Conference
From Elanco Animal Health Incorporated
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.